Navigation Links
Colby Pharmaceutical Company Announces Dramatic Results: Novel Technology Increases Influenza Vaccine Protection for Elderly Rhesus Monkeys
Date:11/5/2013

nts clearly demonstrate that the JVRS-100 adjuvanted flu vaccine is ready to go to the next level in clinical development.” He added, “Colby is seeking vaccine partners for the next phase of development of our JVRS-100 vaccine portfolio.”

“Improving the effectiveness of influenza vaccination for the elderly is a critical public health need,” stated Dr. Robert Malone, M.D., M.S., an internationally recognized vaccine expert. He added that, “Dr. Chris Miller and his colleagues at the Center for Comparative Medicine are among the best non-human primate immunologists and vaccine researchers in the world, and I have confidence in their research findings. In these collaborative studies, Colby has now advanced the CLDC adjuvant to the point that JVRS-100 merits expedited human clinical testing when formulated with pandemic influenza and other respiratory virus vaccine candidates.”

Colby is also clinically developing JVRS-100 CLDC as a stand-alone immune activator drug for cancer patients and, in addition, as an immune activating adjuvant, especially in combination with the influenza vaccine for a seasonal human flu and a pre-pandemic H5N1 vaccine. Colby has developed both therapeutic and preventative applications for JVRS-100, primarily for those medical situations where generation of a robust and durable immune response would be challenging, as in elderly or other immune-compromised individuals.

David Zarling will be discussing Colby Pharmaceutical Company at the East Meets West CEO Conference at the Four Seasons Hotel, San Francisco, CA on January 12, 2014 at 1PM PDT.

About Colby

Colby is developing and selling drug candidates from its pipeline of targeted biologic and small molecules. This includes the JVRS-100 CLDC (Cationic Lipid DNA Complex) biopharmaceutical and small molecule targeted drugs that affect immunity. In 2011, Colby focused its biologics product development on JVRS-100 CLDC as a stand-alone therapy in cance
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. The respective roles of the public and private sectors in pharmaceutical innovation
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... , , , ... cord blood banks, today announced that Shannon Miller , a 7-time ... and will appear in a series of advertising and public awareness campaigns ... ) , , Considered "The Most Decorated American ...
... 24 Boston Scientific Corporation (NYSE: BSX ) will ... trial on Tuesday, September 1, at 8:00 a.m. ET / 2:00 ... call will be hosted by Ray Elliott, President and Chief Executive ... Management; and Arthur Moss, M.D., Professor of Medicine at the University ...
... BOZEN, Italy, August 24 ... its recent partnership announcement with McKesson, it,has received ... North American,customers in just a few days since ... policies prevent them from publicly,commenting on industry events, ...
Cached Biology Technology:7-Time Olympic Medalist Shannon Miller Endorses StemCyte 2Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 3Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 4
(Date:12/17/2014)... 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sensing technology than the iPhone 5S, Samsung introduces ... its product. The Galaxy S5 home ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... currently accepted norms of biofuel production. A commentary published ... of greenhouse gas (GHGs) emissions from bioenergy production are ... of the benefits of biofuels compared to fossil fuels. ... Analysis models of bioenergy production. Life Cycle Analysis (LCA) ...
... be as common as initial HIV infection and is ... study led by researchers at the Johns Hopkins Bloomberg ... Allergy and Infectious Diseases (NIAID). In the first large-scale ... researchers examined the rate of superinfection among a community ...
... with discarded plastics, scientists have been working to produce ... Tel Aviv University researcher is giving the quest for ... making them tougher than ever before. Prof. ... a super-strength polypropylene one of the world,s most ...
Cached Biology News:Environmental benefit of biofuels is overestimated, new study reveals 2New data suggests HIV superinfection rate comparable to initial HIV infection 2New data suggests HIV superinfection rate comparable to initial HIV infection 3Steel-strength plastics -- and green, too! 2Steel-strength plastics -- and green, too! 3
... protein A media yield highly purified ... to analysis of other immunoglobulin classes, ... purification. Protein A binds to the ... from mammalian species. This ready-to-use, bottled ...
... bis- (3-D-Gluconamidopropyl)deoxycholamide White solid. HYGROSCOPIC. ... CHAPSO. Has reduced electrostatic interactions that do ... DEAE-cellulose. Aggregation number: 8-16. Purity: ≥95% ... O. Aggregation number 8 - 16, CMC ...
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Biology Products: